Page 258 - 2021_06-Haematologica-web

from the Francis Crick Institute. DP was supported by a non-clinical junior research fellowship from the European Hematology Association. This work was supported by The Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001045), The UK Medical Research Council (FC001045), and the Welcome Trust (FC001045).
Data sharing statement: scan data are available upon request. Please contact the corresponding author.
References
1.Sant M, Allemani C, Tereanu C, et al. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood. 2010;116(19):3724-3734.
2.Hanoun M, Zhang D, Mizoguchi T, et al. Acute myelogenous leukemia-induced sympathetic neuropathy promotes malignancy in an altered hematopoietic stem cell niche. Cell Stem Cell. 2014; 15(3):365-375.
3. Duarte D, Hawkins ED, Lo Celso C. The interplay of leukemia cells and the bone marrow microenvironment. Blood. 2018;131(14):1507- 1511.
4. Passaro D, Di Tullio A, Abarrategi A, et al. Increased vascular perme- ability in the bone marrow microenvironment contributes to disease progression and drug response in acute myeloid leukemia. Cancer Cell. 2017;32(3):324-341.
5. Padro T, Ruiz S, Bieker R, et al. Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia. Blood. 2000;95(8):2637-2644.
6. Medyouf H. The microenvironment in human myeloid malignan-
cies: emerging concepts and therapeutic implications. Blood. 2017;
129(12):1617-1626.
7. Bixel MG, Kusumbe AP, Ramasamy SK, et al. Flow dynamics and
HSPC homing in bone marrow microvessels. Cell Rep. 2017;18(7):
1804-1816.
8. Itkin T, Gur-Cohen S, Spencer JA, et al. Distinct bone marrow blood
vessels differentially regulate haematopoiesis. Nature. 2016; 532
(7599):323-328.
9. Cuenod CA, Balvay D. Perfusion and vascular permeability: basic
concepts and measurement in DCE-CT and DCE-MRI. Diagn Interv
Imaging. 2013;94(12):1187-1204.
10. Hussong JW, Rodgers GM, Shami PJ. Evidence of increased angio-
genesis in patients with acute myeloid leukemia. Blood. 2000;
95(1):309-313.
11. Subashi E, Choudhury KR, Johnson GA. An analysis of the uncer-
tainty and bias in DCE-MRI measurements using the spoiled gradi-
ent-recalled echo pulse sequence. Med Phys. 2014;41(3):032301.
12. Cao J, Pickup S, Clendenin C, et al. Dynamic contrast-enhanced MRI detects responses to stroma-directed therapy in mouse models of pancreatic ductal adenocarcinoma. Clin Cancer Res. 2019; 25(7):
2314-2322.
13. Hou HA, Shih TT, Liu CY, et al. Changes in magnetic resonance bone
marrow angiogenesis on day 7 after induction chemotherapy can predict outcome of acute myeloid leukemia. Haematologica. 2010; 95(8):1420-1424.
14. Paudyal R, Lu Y, Hatzoglou V, et al. Dynamic contrast-enhanced MRI model selection for predicting tumor aggressiveness in papillary thy- roid cancers. NMR Biomed. 2020;33(1):e4166.
15. Lazzari E, Butler JM. The instructive role of the bone marrow niche in aging and leukemia. Curr Stem Cell Rep. 2018;4(4):291-298.
2286
haematologica | 2021; 106(8)
Letters to the Editor